Efficient and site-specific delivery of therapeutic drugs is a critical challenge in clinical
treatment of cancer. Nano-sized carriers such as liposomes, micelles, and polymeric …

Liposomal drug delivery systems improve the therapeutic index of chemotherapeutic agents,
and the use of cationic liposomes to deliver anticancer drugs to solid tumors has recently …

Nanoscopic vehicles that stably encapsulate drug molecules and release them in response
to a specific trigger are of great interest due to implications in therapeutic applications …

Written at a level comprehensible to non-experts, this handbook covers the current state of
encapsulation and controlled released technologies, presenting the fundamental processes …

Neutral liposomes (NLP) exhibit preferential localization in solid tumors based on the
enhanced permeation and retention (EPR) effect. Cationic liposomes (CLP) have a …

The natural capability shown by cationic vesicles in interacting with negatively charged
surfaces or biomolecules has recently attracted increased interest. Important …

The accelerated blood clearance (ABC) phenomenon, caused in large degree via in vivo
anti-PEG IgM production, is one of obstacles for development of PEGylated liposome and …

Supramolecular nanoassemblies, which are capable of binding and delivering either
lipophilic small molecules or hydrophilic molecules, are of great interest. Concurrently …

Hesperidin methyl chalcone (HMC) is a methylation product of the flavanone hesperidin, a
flavonoid derived from citrus fruits. Many reports have emphasized the analgesic, anti …

Our ability to engineer nanomaterials for biological and medical applications is continuously
increasing, and nanomaterial designs are becoming more and more complex. One very …